PyrazolesSulfonamidesDeoxycytidineDrug Administration ScheduleCyclooxygenase 2 InhibitorsFluorouracilAntineoplastic Combined Chemotherapy ProtocolsEstramustineAdministration, OralTreatment OutcomeCyclooxygenase InhibitorsTaxoidsDrug CombinationsArea Under CurveDrug InteractionsDose-Response Relationship, DrugThalidomideNeutropeniaCyclooxygenase 2Infusions, IntravenousDisease-Free SurvivalAntimetabolites, AntineoplasticNeoplasm MetastasisTime FactorsCisplatinAnti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsDouble-Blind MethodSurvival AnalysisProstaglandin-Endoperoxide SynthasesVomitingCross-Over StudiesNauseaMaximum Tolerated DoseSulfonesProgesteroneDinoprostoneLactonesDiclofenacOrganoplatinum CompoundsPregnancyActivities of Daily LivingFatigueCyclooxygenase 1AdenocarcinomaIsoenzymesNaproxenFollow-Up StudiesNeoplasmsAnticarcinogenic AgentsGastrointestinal DiseasesNeoplasm StagingSurvival RateOsteoarthritisApoptosisIbuprofenDrug Therapy, CombinationPowder DiffractionMembrane ProteinsNipplesThiazinesDisease Models, AnimalPlacebosRats, Sprague-DawleyCell Line, TumorHT29 Cells